It is vital for the pharma manufacturers to invest in anti-counterfeit and anti-tampering measures. It increases customer trust in their products and results in increased market share. Additionally it also results in regulatory compliances.
Tamper evident packaging indicates and alerts the user if a drug has been tampered with in any form and stage before the drug has reached the end-user. The tampering can take form any shape and include:
· Opened container.
· Adulteration of a pharma product.
· Any damage caused to its packaging.
To prevent tampering with the medicine, the packaging is designed in a way that cannot be corrected or converted to the default form. It also enables the user to detect tampering as the tampering evidence cannot be hidden. Restoring packaging can only be carried out in the manufacturer’s facility.
Anti-counterfeit packaging is also specialized packaging that prevents the manufacturing of unauthorized products of the drugs. These products contain specialized safety features that can only be created or applied at the manufacturing facility. These unauthorized productions are sub-standard products manufactured with the intent of earning money or damaging the manufacturer’s reputation.
Commonly counterfeit products involve labels with wrong information showing incorrect drug ingredients. Anti-counterfeit packaging includes unique features and uses the latest technology that cannot be copied or reproduced in any facility except in the manufacturer’s facility.
Consequences of Tamper and Counterfeit Products
There are various consequences of tampering and counterfeit pharma products that can affect both the manufacturers and the users. It only benefits the producer of these tampered with and fake products.
There are un-limited hazards and harmful effects of these tampered with and counterfeit products. Some of them are briefed below.
Punishment by Regulatory Bodies
It is the responsibility of the drug manufacturers to adopt effective measures that prevent tampering and counterfeit of its medicines and products. Medical supplies manufacturers are also responsible for developing resources to implement these features.
If the manufacturer fails to implement Tamper evident and anti-counterfeit features for its products, regulatory bodies can issue a warning letter, impose a fine, or shut down its operations. Regulatory bodies impose these types of strictness because they have failed to implement such safety measures for their medicines in their respective markets.
Damage to manufacturer’s reputation
Tampered and Counterfeit products significantly damage the manufacturer’s reputation, which costs them to lose valuable market share against their competitors. The user loses confidence in the manufacturer’s ability to produce quality medicines, and its effect can be felt for a more extended period. It also establishes a wrong impression in the mind of its customers about poor quality processes and equipment being used in the manufacturing facility.
Once the manufacturer is affected by all these factors and loses its position in the market, it is quickly replaced by its competitors. It can take days, sometimes months, to take back its market share if the manufacturer loses its share.
Adverse effects on end user and patients
The end-user is the most affected party due to tampering with counterfeit products. These medicines can result in severe effects on the patients' health and even cause life-threatening consequences. Some treatments and drugs are used as life-saving, and they are vital for the patients for ...
(All Rights Reserved)